Cytochrome c release from rat liver mitochondria is compromised by increased saturated cardiolipin species induced by sucrose feeding

American Journal of Physiology - Endocrinology and Metabolism

Volumn 309, Issue 9, 2015, Pages E777-E786

  Ruiz Ramírez, Angélica ^a   Barrios Maya, Miguel Angel ^a   López Acosta, Ocarol ^a   Molina Ortiz, Dora ^b   El Hafidi, Mohammed ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Cardiolipin; Cytochrome c release; Mitochondria; Reactive oxygen species; Sucrose diet

Indexed keywords

CARDIOLIPIN; CATALASE; CYTOCHROME C; EBSELEN; HYDROGEN PEROXIDE; LINOLEIC ACID; MACROGOL; MALIC ACID; MEMBRANE PROTEIN; PALMITIC ACID; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; SUCCINIC ACID; SUCROSE; SUPEROXIDE; TAFAZZIN; UNCLASSIFIED DRUG; XANTHINE; XANTHINE OXIDASE; CARBOHYDRATE DIET;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; FATTY LIVER; INNER MEMBRANE; LIPID MEMBRANE; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RAT; SUGAR INTAKE; ANIMAL; CARBOHYDRATE DIET; DRUG EFFECTS; LIVER; METABOLISM; OXIDATION REDUCTION REACTION; PHARMACOLOGY; WISTAR RAT;

ANIMALS; CARDIOLIPINS; CYTOCHROMES C; DIETARY CARBOHYDRATES; HYDROGEN PEROXIDE; LIVER; MALE; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUCROSE;

EID: 84946019834     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00617.2014     Document Type: Article

References (41)

1. Abe M, Niibayashi R, Koubori S, Moriyama I, Miyoshi H. Molecular mechanisms for the induction of peroxidase activity of the cytochrome c-cardiolipin complex. Biochemistry 50: 8383-8391, 2011.
2. Aoun M, Fouret G, Michel F, Bonafos B, Ramos J, Cristol JP, Carbonneau MA, Coudray C, Feillet-Coudray C. Dietary fatty acids modulate liver mitochondrial cardiolipin content and its fatty acid composition in rats with non alcoholic fatty liver disease. J Bioenerg Biomembr 44: 439-452, 2012.
3. Bai J, Rodriguez AM, Melendez JA, Cederbaum AI. Overexpression of catalase in cytosolic or mitochondrial compartment protects HEPG2 cells against oxidative injury. J Biol Chem 274: 26217-26224, 1999.
4. Belikova NA, Vladimirov YA, Osipov AN, Kapralov AA, Tyurin VA, Potapovich MV, Basova LV, Peterson J, Kurnikov IV, Kagan VE. Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes. Biochemistry 45: 4998-5009, 2006.
5. Bouchier-Hayes L, Lartigue L, Newmeyer DD. Mitochondria: pharmacological manipulation of cell death. J Clin Invest 115: 2640-2647, 2005.
6. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147-152, 2004.
7. Caldwell SH, Chang CY, Nakamoto RK, Krugner-Higby L. Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis 8: 595-617, 2004.
8. Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 292: C33-C44, 2007.
9. Crouser ED, Gadd ME, Julian MW, Huff JE, Broekemeier KM, Robbins KA, Pfeiffer DR. Quantitation of cytochrome c release from rat liver mitochondria. Anal Biochem 317: 67-75, 2003.
10. El-Hafidi M, Meschini MC, Rizza T, Santorelli FM, Bertini E, Carrozzo R, Vázquez-Memije ME. Cardiolipin content in mitochondria from cultured skin fibroblasts harboring mutations in the mitochondrial ATP6 gene. J Bioenerg Biomembr 43: 683-690, 2011.
11. Folch L, Lees M, Sloane-Stanley CH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 22: 697-709, 1957.
12. Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 30: 121-138, 2004.
13. Gebert N, Joshi AS, Kutik S, Becker T, McKenzie M, Guan XL, Mooga VP, Stroud DA, Kulkarni G, Wenk MR, Rehling P, Meisinger C, Ryan MT, Wiedemann N, Greenberg ML, Pfanner N. Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for barth syndrome. Curr Biol 19: 2133-2139, 2009.
14. 2+ -independent mechanisms that are regulated by bax. J Biol Chem 276: 19066-19071, 2001.
15. Green DR. Apoptotic pathways: ten minutes to dead. Cell 121: 671-674, 2005.
16. Han X, Yang J, Yang K, Zhao Z, Abendschein DR, Gross RW. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry 46: 6417-6428, 2007.
17. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med 361: 1570-1583, 2009.
18. Hunter DR, Haworth RA, Southard JH. Relationship between configuration, function, and permeability in calcium treated mitochondria. J Biol Chem 251: 5069-5077, 1976.
19. Ishimoto T, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Orlicky DJ, Cicerchi C, McMahan RH, Abdelmalek MF, Rosen HR, Jackman MR, MacLean PS, Diggle CP, Asipu A, Inaba S, Kosugi T, Sato W, Maruyama S, Sánchez-Lozada LG, Sautin YY, Hill JO, Bonthron DT, Johnson RJ. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 58: 1632-1643, 2013.
20. Iverson SL, Enoksson M, Gogvadze V, Ott M, Orrenius S. Cardiolipin is not required for Bax-mediated cytochrome c release from yeast mitochondria. J Biol Chem 279: 1100-1107, 2004.
21. Iverson SL, Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 423: 37-46, 2004.
22. James AM, Collins Y, Logan A, Murphy MP. Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 23: 429- 434, 2012.
23. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223-232, 2005.
24. Kelley EE, Khoo NKH, Hundley NJ, Malik UZ, Freeman BA, Tarpey MM. Hydrogen peroxide is the major oxidant product of xanthine oxidase. Free Radic Biol Med 48: 493-498, 2010.
25. Madesh M, Hajnóczky G. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155: 1003-1015, 2001.
26. Mantena SK, Vaughn DP, Andringa KK, Eccleston HB, King AL, Abrams GA, Doeller JE, Kraus DW, Darley-Usmar VM, Bailey SM. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 417: 183-193, 2009.
27. Lowry OH, Rosebrough NJ, Farr A, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
28. Lucken-Ardjomande S, Montessuit S, Martinou JC. Contributions to BAX insertion and oligomerization of lipids of the mitochondrial outer membrane. Cell Death Differ 15: 929-937, 2008.
29. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47: 143-183, 2007.
30. Ostrander DB, Sparagna GC, Amoscato AA, McMillin JB, Dowhan W. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J Biol Chem 276: 38061- 38067, 2001.
31. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 99: 1259-1263, 2002.
32. Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol 42: 928-940, 2005.
33. Petrosillo G, Ruggiero FM, Paradies G. Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB J 17: 2202-2208, 2003.
34. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 52: 59-69, 2012.
35. Ruiz-Ramírez A, Chávez-Salgado M, Peñeda-Flores JA, Zapata E, Masso F, El-Hafidi M. High-sucrose diet increases ROS generation, FFA accumulation, UCP2 level, and proton leak in liver mitochondria. Am J Physiol Endocrinol Metab 301: E1198-E1207, 2011.
36. Sarma BK, Mugesh G. Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions. J Am Chem Soc 127: 11477-11485, 2005.
37. Schwall CT, Greenwood VL, Alder NN. The stability and activity of respiratory Complex II is cardiolipin-dependent. Biochim Biophys Acta 1817: 1588-1596, 2012.
38. Sies H, Masumoto H. Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv Pharmacol 38: 229 -246, 1997.
39. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander- Tetri BA. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 295: G987-G995, 2008.
40. Trauner M, Arrease M, Wangner M. Fatty liver and lipotoxicity. Biochim Biophys Acta 180: 299-310, 2010.
41. Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis 5: e996, 2014.